Médecins

Docteur Deltenre P.

Accueil / Liste des médecins / Docteur Deltenre P.

Docteur DELTENRE Pierre

Hépato-gastroentérologue, maître de stage

Service de Gastro-Entérologie

Centre(s) d’intérêt :

  • Les maladies du foie

Contacts

  • secrétariat planning : 081/20.96.61
  • secrétariat consultations : 081/20.90.91

Diplômes :

  • 1992 : Diplôme de Master en médecine (UCL) – Grande Distinction
  • 1997 : Diplôme de Master de spécialisation en Hépato-gastro-entérologie (UCL)

Diplômes complémentaires :

  • 2009 : Certificat de formation à la recherche (Formation doctorale) – ULB
  • 2012 : Docteur en Sciences Médicales (Ph.D.) (3ème cycle universitaire) – ULB
  • 2014 : Professeur Assistant (Privat-docent) – Maître d’enseignement et de recherche type 1, Centre Hospitalier Universitaire Vaudois, Université de Lausanne, Suisse
  • 2017 : MicroMBA CHUV (Master of Business Administration) – Centre Hospitalier Universitaire Vaudois, Lausanne, Suisse
  • 2019 : Maitre de Conférence, Faculté de Médecine, ULB
  • 2020 : Certificat de compétence en Radioprotection physique et biologique

Parcours professionnel :

  • 1997-1999 : Consultations d’hépatologie sous la direction du Professeur D. VALLA, Hôpital Beaujon, Clichy, France
  • 1999 à 2013 : Praticien Hospitalier Attaché au Service d’hépato gastroentérologie (Professeur A. CORTOT, Professeur P. MATHURIN), Centre Hospitalier Régional Universitaire de Lille, France
  • 2001 à 2013 : Adjoint du Service d’hépato-gastroentérologie, Hôpital de Jolimont, 159, rue Ferrer, 7100, Haine-Saint-Paul
  • 2004-2013 : Membre du conseil scientifique de l’association de malades de l’hépatite C « Carrefour Hépatite – Aide et Contact » (CHAC)
  • 2010-2013 : Secrétaire de l’Unité d’Etudes Cliniques, Centres Hospitaliers de Jolimont-Lobbes
  • 2013 à ce jour : Consultant dans le Département de gastro-entérologie, d’hépato-pancréatologie et d’oncologie digestive de l’Hôpital Erasme (Professeur J. DEVIERE), ULB
  • 2013 à 2017 : Médecin Cadre, Service de Gastro-entérologie et d’Hépatologie, Centre Hospitalier Universitaire Vaudois (Professeur D. MORADPOUR), Université de Lausanne, Suisse
  • 2018 à ce jour : Médecin adjoint, Service de Gastro-entérologie et d’Hépatologie, Clinique Saint-Luc Bouge
  • 2019 : Maitre de stage pour la formation de médecins spécialistes en gastro entérologie, Clinique Saint-Luc Bouge
  • 2021 à ce jour : Consultant dans le service d’Hépato-gastroentérologie, CHU UCL Mont-Godinne

Pourquoi j’exerce à la Clinique Saint-Luc Bouge :

« J’ai choisi d’exercer à la Clinique Saint-Luc Bouge car j‘apprécie son caractère familial. La médecine que l’on y fait est de qualité et le service de Gastro-entérologie jouit d’une excellente renommée. »

Publications :

ARTICLES ORIGINAUX DANS DES REVUES A COMITE DE LECTURE

  • Deltenre P, Henrion J, Jacques JM, Schapira M, Ghilain JM, Maisin JM, Heller FR. Hépatite toxique due à la prise d’ecstasy : rapport d’un cas probable et revue de la littérature. Acta Gastroenterol Belg 1994; 57: 341-5.
  • de Meester A, Deltenre P, Chaudron JM. Extreme prolongation of the QT interval observed in massive pulmonary embolism. Acta Clin Belg 1995; 50: 301-4.
  • Deltenre P, Ghilain JM, Maisin JM, Schapira M, Henrion J, Heller FR. Le rapport lipase/amylase permet-il d’identifier les pancréatites aiguës alcooliques ? Acta Gastroenterol Belg 1995; 58: 222-9.
  • Schapira M, Gerard R, Deltenre P, Henrion J, Ghilain JM, Maisin JM, Schmitz A, Heller FR. An unusual cause for left sided colitis: hot-water enema. Acta Gastroenterol Belg 1996; 59: 220-1.
  • Deltenre P, Berson A, Marcellin P, Degott C, Biour M, Pessayre D. Mesalazine (5-aminosalicylic acid) induced chronic hepatitis. Gut 1999; 44: 886-8.
  • Deltenre P, Denninger MH, Hillaire S, Guillin MC, Casadevall N, Briere J, Erlinger S, Valla DC. Factor V Leiden-related Budd-Chiari syndrome. Gut 2001; 48: 264-8.
  • Moreau R, Chagneau C, Heller J, Chevenne D, Langlet P, Deltenre P, Hillaire S, Lefilliatre P, Pateron D, Sogni P, Valla D, Lebrec D. Hemodynamic, metabolic and hormonal responses to oral glibenclamide in patients with cirrhosis receiving glucose. Scand J Gastroenterol 2001; 36: 303-8.
  • Deltenre P, Rufat P, Hillaire S, Elman A, Moreau R, Valla D, Lebrec D. Lack of prognostic usefulness of hepatic venous pressure and hemodynamic values in a select group of patients with severe alcoholic cirrhosis. Am J Gastroenterol 2002; 97: 1187-90.
  • Henrion J, De Maeght S, Deltenre P, Ghilain JM, Maisin JM, Schapira M, Heller F. Impact of hepatitis C virus infection on the aetiology of cirrhosis and hepatocarcinoma in three affiliated hospitals in southern Belgium. Acta Gastroenterlol Belg 2002; 65: 80-2.
  • Henrion J, Libon E, De Maeght S, Deltenre P, Schapira M, Ghilain JM, Maisin JM, Heller FR. Faisabilité et résultats de la surveillance du carcinome hepatocellulaire dans une cohorte de cirrhoses d’origine principalement alcoolique. Gastroenterol Clin Biol 2003; 27: 534-39.
  • Deltenre P, Henrion J, Canva V, Texier F, Dharancy S, Louvet A, De Maeght S, Paris JC, Mathurin P. Evaluation of amantadine in chronic hepatitis C: a meta-analysis. J Hepatol 2004; 41: 462-73.
  • Deltenre P, Mathurin P, Dharancy S, Moreau R, Bulois P, Henrion J, Sergent-Baudson G, Ernst O, Paris JC, Lebrec D. Transjugular intrahepatic portosystemic shunt (TIPS) in refractory ascites: a meta-analysis. Liver Int 2005; 25: 349-56.
  • Louvet A, Texier F, Dharancy S, Pruvot FR, Sergent G, Deltenre P, Ernst O, Paris JC, Mathurin P. Anticoagulation therapy may reverse biliary abnormalities due to acute portal thrombosis. Dig Dis Sci 2006; 51: 11-7.
  • Gonzalez F, Dharancy S, Condat B, Deltenre P, Mathurin P, Paris, JC. Extensive portal vein thrombosis related to abdominal trauma. Gastroenterol Clin Biol 2006; 30: 314-16.
  • Mathurin P, Gonzalez F, Kerdraon O, Leteurtre E, Arnalsteen L, Hollebecque A, Louvet A, Dharancy S, Cocq P, Jany T, Boitard J, Deltenre P, Romon M, Pattou F. The evolution of severe steatosis after bariatric surgery is related to insulin resistance. Gastroenterology 2006 ; 130: 1617-24.
  • Louvet A, Naveau S, Abdelnour M, Ramond MJ, Diaz E, Fartoux L, Dharancy S, Texier F, Hollebecque A, Serfaty L, Boleslawski E, Deltenre P, Canva V, Pruvot FR, Mathurin P. The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. Hepatology 2007; 45: 1348-54.
  • Louvet A, Diaz E, Coevoet H, Dharancy S, Texier F, Thévenot T, Deltenre P, Canva V, Plane C, Mathurin P. Early switch to pentoxifylline in patients with severe alcoholic hepatitis is inefficient in non-responders to corticosteroids. J Hepatol 2008; 48: 465-70.
  • Peyrin-Biroulet L, Deltenre P, de Suraÿ N, Branche J, Sandborn WJ, Colombel J. Efficacy and safety of Anti-tumour Necrosis Factor Blocking Agents in Crohn’s Disease: a Meta-Analysis of Placebo-Controlled Trials. Clin Gastroenterol Hepatol 2008; 6: 644-53.
  • Deuffic-Burban S, Deltenre P, Louvet A, Canva V, Dharancy S, Hollebecque A, Boitard J, Henrion J, Yazdanpanah Y, Mathurin P. Impact of viral eradication on mortality related to hepatitis C using a modeling approach. J Hepatol 2008; 49: 175-83.
  • Grisart B, Rack K, Vidrequin S, Hilbert P, Deltenre P, Verellen-Dumoulin C, Destrée A. NF1 microduplication first clinical report: association with mild mental retardation, early onset of baldness and dental enamel hypoplasia? European Journal of Human Genetics 2008; 16: 305-11.
  • Henrion J, Schapira M, Ghilain JM, Maisin JM, De Maeght S, Deltenre P, Moulart M, Delaunoit T. Mais que sont devenues les hémorragies digestives d’antan ? Gastroentérol Clin Biol 2008; 32: 839-47.
  • Deltenre P, Canva V, El Nadi M, François C, Castelain S, Dharancy S, Louvet A, Bocket L, Lazrek M, Hollebecque A, Wartel F, Henrion J, Duverlie G, Mathurin P. A 2-log drop in viral load at 1 month is the best predictor of sustained response in HCV patients with normal ALT: a kinetic prospective study. J Viral Hepatitis 2009; 16: 500-5.
  • Deltenre P, Peny MO, Dufour A, El Nady M, Henrion J. Acute hepatitis induced by glatiramer acetate. BMJ Case Reports 2009 [doi:10.1136/bcr.09.2008.0913].
  • Peyrin-Biroulet L, Deltenre P, Ardizzone S, D’Haens G, Hanauer SB, Herfarth H, Lémann M, Colombel JF. Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn’s disease: a meta-analysis of controlled trials with individual patient data. Am J Gastroenterol 2009; 104: 2089-96.
  • Brenard R, Chapaux X, Deltenre P, Henrion J, Horsmans Y, Borbath Y, Leenaerts A, Van Cauter J, Francque S, Sersté T, Moreno C, Mengeot P, Lerut J, Sempoux C. Large spectrum of liver vascular lesions including high prevalence of focal nodular hyperplasia in patients with hereditary haemorrhagic telangiectasia: the Belgian Registry based on 30 patients. Eur J Hepatol Gastroenterol 2010; 22:1253-9.
  • Louvet A, Wartel F, Castel H, Dharancy S, Hollebecque A, Canva V, Deltenre P, Mathurin P. Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor. Gastroenterology 2009; 137: 541-8.
  • Deuffic-Burban S, Babany G, Lonjon-Domanec I, Deltenre P, Canva-Delcambre V, Dharancy S, Louvet A, Roudot-Thoraval F, Mathurin P. Impact of Pegylated Interferon and Ribavirin on morbidity and mortality in patients with chronic hepatitis C and normal transaminases. Hepatology 2009; 50: 1351-9.
  • Moreno C*, Deltenre P*, Pawlotsky JM, Henrion J, Adler M, Mathurin P. Shortened treatment duration in treatment-naive genotype 1 HCV patients with rapid virological response: a meta-analysis. J Hepatol 2010; 52: 25-31. *Co 1er auteur
  • Henrion J, Deltenre P, Peny MO, Dumoulin P, Laurent Y, Brenard R. Fatal hypoxic hepatitis in a patient with hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber’s disease). Acta Gastroenterol Belg 2010; 73: 52-54.
  • Henrion J, Deltenre P, De Maeght S, Schapira M. Acute lower limb ischemia as a triggering condition in hypoxic hepatitis. A study of five cases. J Clin Gastroenterol 2011; 45: 274-277.
  • Francque S, De Maeght S, Adler M, Deltenre P, de Galoscy C, Orlent H, Van Steenbergen W, Bastens B, Wain E, Langlet P, Lasser L, Verlinden W, Van Marck E, Henrion J and the steering committee of the Belgian Association for the Study of the Liver. High prevalence of advanced fibrosis in association with the metabolic syndrome in a Belgium prospective cohort of NAFLD patients with elevated ALT. Results of the Belgian Belgian NAFLD registry. Acta Gastroenterol Belg 2011; 74: 9-16.
  • Deltenre P, Corouge M, Canva V, Castel H, Wartel F, Dharancy S, Louvet A, Lazrek M, Moreno C, Henrion J, Mathurin P. Usefulness of viral kinetics for early prediction of a sustained virological response in HCV-1 non-responders re-treated with pegylated interferon and ribavirin. J Hepatol 2011; 55: 989-95.
  • Deltenre P, Louvet A, Lemoine M, Mourad A, Fartoux L, Moreno C, Henrion J, Mathurin P, Serfaty L. Impact of insulin resistance on sustained response in HCV patients treated with pegylated interferon and ribavirin: a meta-analysis. J Hepatol 2011; 55: 1187-94.
  • Trépo E, Gustot T, Degré D, Lemmers A, Verset L, Demeeter P, Ouziel R, Quertinmont E, Vercruysse V, Amininejad L, Deltenre P, Le Moine O, Devière J, Franchimont D, Moreno C. Common polymorphism in the PNPLA3/adiponutrin gene confers higher risk of cirrhosis and liver damage in alcoholic liver disease. J Hepatol 2011; 55: 906-12.
  • Deltenre P, Laleman W, van Gossum M, Lenaerts A, Colle I, Adler M, Michielsen P, Assene C, Delwaide J, Orlent H, Reynaert H, D’Heygere F, Langlet P, Robaeys G, de Galocsy C, Brenard R, Sprengers D, Mairlot MC, Preux C, Lefèbvre V, Henrion J. Are less restrictive criteria more appropriate for defining inactive HBV carriers in clinical practice? Results of the Belgian Association for the Study of the Liver observatory of 1,456 chronic HBsAg Acta Gastroenterol Belg 2012; 75: 35-41.
  • Deltenre P, Moreno C, Tran A, Castel H, El Nady M, Canva V, Louvet A, Colin M, Provot F, Glowacki F, Dharancy S, Stanke F, Henrion J, Noel C, Mathurin P. Antiviral therapy in hemodialyzed HCV patients: efficacy, tolerance and treatment strategy. Aliment Pharmacol Ther 2011; 34: 354-61.
  • Boleslawski E, Petrovai G, Truant S, Dharancy S, Duhamel A, Deltenre P, Sulaberidze L, Zerbib P, Lebuffe G, Mathurin P, Pruvot FR. Hepatic venous pressure gradient is a predictive factor of mortality after liver resection for hepatocellular carcinoma in cirrhotic patients. Br J Surg 2012; 99:855-63.
  • Henrion J, Deltenre P, De Maeght S, Ghilain JM, Maisin JM, Moulart M, Delaunoit T, Verset D, Yeung CPR, Schapira M. Acute upper gastrointestinal bleeding in cirrhosis: Changes and advances over the past two decades. Acta Gastroenterol Belg 2011;74:381-8.
  • Deuffic-Burban S, Deltenre P, Buti M, Stroffolini T, Parkes J, Mühlberger N, Siebert U, Moreno C, Hatzakis A, Rosenberg W, Zeuzem S, Mathurin P. Predicted effects of treatment for HCV infection vary among European countries. Gastroenterology 2012; 143: 974-85.
  • Schreiber J, Moreno C, Garcia Garcia B, Louvet A, Trepo E, Henrion J, Thabut D, Mathurin P, Deltenre P. Meta-analysis: the impact of IL28B polymorphisms on rapid and sustained virological response in HCV-2 and -3 patients. Aliment Pharmacol Ther 2012;36:353-62.
  • Trépo E, Ouziel R, Pradat P, Momozawa Y, Quertinmont E, Gervy C, Gustot T, Degré D, Vercruysse V, Deltenre P, Gulbis B, Franchimont D, Devière J, Lemmers A, Moreno C. Moreno C. Marked 25-hydroxyvitamin D deficiency is associated with poor prognosis in patients with alcoholic liver disease. J Hepatol 2013;59:344-50.
  • Ho E, Deltenre P, Nkuize M, Delwaide J, Colle I, Michielsen P. Coinfection of hepatitis B and hepatitis delta virus in Belgium: a multicenter BASL study. Prospective epidemiology and comparison with HBV mono-infection. J Med Virol 2013;85:1513-17.
  • de Vos M, De Vroey B, Garcia Garcia B, Roy C, Kidd F, Henrion J, Deltenre P. The role of proton pump inhibitors in the occurrence and prognosis of spontaneous bacterial peritonitis in cirrhotic patients with ascites. Liv Int 2013;33:1316-23.
  • De Vroey B, Moreno C, Laleman W, van Gossum M, Colle I, de Galocsy C, Langlet P, Robaeys G, Orlent H, Michielsen P, Delwaide J, Reynaert H, D’Heygere F, Sprengers D, Bourgeois S, Assene C, Vos B, Brenard R, Adler M, Henrion J, Deltenre P. HBV and HCV infections in Belgium: similarities and differences in epidemics and in initial management. Eur J Gastroenterol Hepatol 2013;25:613-19.
  • Deuffic-Burban S, Mathurin P, Rosa I, Bouvier AM, Cannesson A, Mourad A, Canva V, Louvet A, Deltenre P, Boleslawski A, Truant S, Pruvot FR, Dharancy S. Impact of emerging hepatitis C virus treatments on future needs for liver transplantation in France: a modelling approach. Dig Liv Dis 2014;46:157-63.
  • Deuffic-Burban S, Schwarzinger M, Obach D, Mallet V, Pol S, Pageaux GP, Canva-Delcambre V, Deltenre P, Roudot-Thoraval F, Larrey D, Dhumeaux D, Mathurin P, Yazdan Yazdanpanah. Should we await IFN-free regimens to treat HCV genotype 1 treatment-naive patients? A cost-effectiveness analysis (ANRS 95141). J Hepatol 2014;61:7-14.
  • Trépo E, Nahon P, Bontempi G, Valenti L, Falleti E, Nischalke HD, Hamza S, Corradini SG, Burza MA, Guyot E, Donati B, Spengler U, Hillon P, Toniutto P, Henrion J, Franchimont D, Devière J, Mathurin P, Moreno C, Romeo S, Deltenre P. Association between PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: evidence from a meta-analysis of individual participant data. Hepatology 2014;59:2170-77.
  • Bourgeois S, Deltenre P, Delwaide J, Henrion J, Adler M, Langlet P, Mulkay JP, Nevens F, Brixko C, Moreno C. A non-interventional phase IV Belgian survey to assess the antiviral effectiveness of pegylated interferon-alpha-2b and ribavirin treatment according to the stage of liver fibrosis in previously untreated patients with genotype 1/4/5/6 chronic hepatitis C (PRACTICE). Acta Gastroenterol Belg 2014;77:393-400.
  • Sersté T, Njimi H, Degré D, Deltenre P, Schreiber J, Lepida A, Trépo E, Gustot T, Moreno C. The use of beta-blockers is associated with the occurrence of acute kidney injury in severe alcoholic hepatitis. Liv Int 2015;35:1074-82.
  • Deltenre P, Trépo E, Rudler M, Monescillo A, Fraga M, Denys A, Doerig C, Fournier N, Moreno C, Moradpour D, Bureau C, Thabut D. Early transjugular intrahepatic portosystemic shunt in cirrhotic patients with acute variceal bleeding: a meta-analysis of controlled trials. Eur J Gastroenterol Hepatol 2015;27:e1-e9.
  • Buch S, Stickel F, Trepo E, Way M, Herrmann A, Nischalke HD, Brosch M, Rosendahl J, Berg T, Ridinger M, Rietschel M, McQillin A, Frank J, Kiefer F, Schreiber S, Lieb W, Soyka M, Semmo N, Datz C, Schmelz R, Brückner S, Wodarz N, Devière J, Clumeck N, Sarrazin C, Lammert F, Gustot T, Deltenre P, Völzke H, Lerch M, Mayerle J, Eyer F, Schafmayer C, Nothnagel M, Franke A, Moreno C, Franchimont D, Morgan MY, Hampe J. A three-stage genome-wide association study identifies SUGP1/TM6SF2 and TMC4/MBOAT7 as risk loci for alcoholic liver cirrhosis. Nat Genet. 2015 Oct 19. doi: 10.1038/ng.3417.
  • Marot A, Trépo E, Doerig C, Moreno C, Moradpour D, Deltenre P. Systematic review with meta-analysis: self-expanding metal stents in patients with cirrhosis and severe or refractory esophageal variceal bleeding. Aliment Pharmacol Ther 2015;42:1250-60.
  • Arain A, Bourgeois S, de Galocsy C, Deltenre P, d’Heygere F, Georges C, Bastens B, Van Overbeke L, Verrando R, Bruckers L, Mathei C, Buntinx F, Van Vlierberghe H, Francque S, Laleman W, Moreno C, Nevens F, Robaeys G. The Belgian experience in treatment of PWID and non-PWID with the new standard of care in genotype 1 infected patients. J Med Virol 2016;88:94-9.
  • Degré D, Gustot T, Verset L, Gerkens A, Boon N, Schreiber J, Lepida A, Sersté T, Deltenre P, Devière J, Trépo E, Moreno Insulin resistance is associated with cirrhosis and portal hypertension in alcoholic liver disease patients. Eur J Gastroenterol Hepatol 2016;28:792-96.
  • Moreno C, Deltenre P, Senterre C, Louvet A, Gustot T, Bastens B, Hittelet A, Piquet MA, Laleman W, Orlent H, Lasser L, Sersté T, Starkel P, Dekoninck X, Negrin S, Delwaide J, Colle I, de Galocsy C, Francque SM, Langlet P, Putzeys V, Reynaert H, Degré D, Trépo E. Intensive enteral nutrition in severe alcoholic hepatitis patients treated with corticosteroids: a multicenter randomized controlled trial. Gastroenterology 2016;150:903-10.
  • Vandenbulcke H, Moreno C, Colle I, Knebel JF, Francque S, Sersté T, George C, de Galocsy C, Laleman W, Delwaide J, Orlent H, Lasser L, Trépo E, Van Vlierberghe H, Michielsen P, van Gossum M, de Vos M, Marot A, Doerig C, Adler M, Henrion J, Deltenre P. Alcohol intake increases the risk of hepatocellular carcinoma in HCV-related compensated cirrhosis: a prospective study. J Hepatol 2016;65:543-61.
  • Feloni S, Descamps O, de Vos M, De Vroey B, Vandenbulcke H, Doerig C, Marot A, Henrion J, Deltenre P. Diagnosis accuracy of ALT and waist circumference as a screening test for insulin resistance. Acta Gastroenterol Bel 2016;79:455-65.
  • Schoepfer AM, Vavricka S, Safroneeva E, Fournier N, Manser C, Frei P,Deltenre P, Rogler G, Straumann A, Ezri J, Nydegger A, Braegger C. Systematic Evaluation of Diagnostic Delay in Pediatric Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition 2017;64:245-47.
  • Monier A, Guiu B, Duran R, Aho S, Bize P, Deltenre P, Dunet V, Denys A. Liver and Biliary Damages Following Transarterial Chemoembolization of Hepatocellular Carcinoma: Comparison Between Drug-Eluting Beads and Lipiodol Emulsion. Eur Radiol 2017;4:1431-39.
  • De Gottardi A, Trebicka J, Klinger C, Plessier A, Seijo S, Terziroli B, Magenta L, Semela D, Buscarini E, Langlet P, Görtzen J, Puente A, Müllhaupt B, Navascuès C, Nery F, Deltenre P, Turon F, Engelmann C, Arya R, Caca K, Peck-Radosavljevic M, Leebeek F, Valla D, Garcia-Pagan JC, on behalf of the VALDIG Investigators. Use of direct-acting oral anticoagulants (DOACs) in patients with portal hypertension. Liv Int 2017;37:694-99.
  • Marot A, Trépo E, Doerig C, Schoepfer A, Moreno C, Deltenre P. Liver stiffness and platelet count for identifying patients with compensated liver disease at low risk of variceal Liv Int 2017;37:707-13.
  • Leporq B, Daire JL, Pastor CM, Deltenre P, Sempoux C, Schmidt S, Van Beers BE. Quantification of hepatic perfusion and hepatocyte function with dynamic gadoxetic acid-enhanced MR imaging in patients with chronic liver disease. Clin Sci 2018;132:813-24.
  • Bruggmann P, Blach S, Deltenre P, Fehr J, Kouyos R, Lavanchy D, Müllhaupt B, Rauch A, Razavi H, Schmid P, Semela D, Stöckle M, Negro F. Hepatitis C virus dynamics among intravenous drug users suggest that an annual treatment uptake above 10% would eliminate the disease by 2030. Swiss Medical Weekly 2017;147:w14543.
  • Marot A, Belaid A, Orlent H, Sersté T, Michielsen P, Colle I, Laleman W, de Galocsy C, Reynaert H, D’Heygere F, Moreno C, Doerig C, Henrion J, Deltenre P. Characteristics of patients with hepatitis B virus and hepatitis C virus dual infection in a Western European country: comparison with monoinfected patients. Clinics and Research in Hepatology and Gastroenterology 2017;41:656-63.
  • Marot A, Henrion J, Knebel JF, Moreno C, Deltenre P. Alcoholic liver disease confers a worse prognosis than HCV infection and non-alcoholic fatty liver among patients with cirrhosis. Plos One 2017;12:e0186715.
  • Marot A, Dubois M, Trépo E, Moreno C, Deltenre P. Liver transplantation for alcoholic hepatitis: a systematic review with meta-analysis. Plos One 2018;13(1):e0190823.
  • Trépo E, Goossens N, Fujiwara N, Song WM, Colaprico A, Marot A, Spahr L, Demetter P, Sempoux C, Gustot T, Thung SN, Devière J, Im GY, Minsart C, Sersté T, Bontempi G, Abdelrahman K, Quertinmont E, Henrion J, Degré D, Lucidi V, Rubbia-Brandt L, Nair VD, Moreno C, Deltenre P*, Hoshida Y*, Franchimont D*. gs-MELD score: an integrative transcriptomic and clinical predictor of survival in severe alcoholic hepatitis. Gastroenterology 2018;154:965-75. * Co dernier auteur
  • Stickel F, Buch S, Nischalke HD, Weiss KH, Gotthardt D, Fischer J, Rosendahl J, Marot A, Elamly M, Casper Markus, Lammert F, McQuillin A, Zopf S, Spengler U, Marhenke S, Kirstein M, Vogel A, Eyer F, von Felden J, Wege H, Buch H, Schafmayer C, Braun F, Deltenre P*, Berg T*, Morgan MY*, Hampe J*. Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosis. Am J Gastroenterol 2018;113:1475-83. * Co dernier auteur
  • Sersté T, Cornillie A, Njimi H, Pavesi M, Arroyo V, Putignano A, Weichselbaum L, Deltenre P, Degré D, Trépo E, Moreno C, Gustot T. The prognostic value of acute-on-chronic liver failure during the course of severe alcoholic hepatitis. J Hepatol 2018;69:318-24.
  • Vietti Violi N, Duran R, Guiu B, Cercueil JP, Aubé C, Digklia A, Pache I, Deltenre P, Knebel JF, Denys A. Efficacy of microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma in patients with a chronic liver disease: a randomized controlled phase 2 trial. Lancet Gastroenterol Hepatol 2018;3:317-25.
  • Marot A, Vieira Barbosa J, Duran R, Deltenre P*, Denys A*. Recanalization success rate of chronic portal vein occlusion in symptomatic non cirrhotic patients depends on the extension of the occlusion: Proposal of a new classification. Diagnostic and Interventional Imaging 2019;100:147-56. * Co dernier auteur
  • Strnad P, Buch S, Hamesch K, Fischer J, Rosendahl J, Schmelz R, Brueckner S, Brosch M, Heimes CV, Woditsch V, Scholten D, Nischalke HD, Janciauskiene S, Mandorfer M, Trauner M, Way MJ, McQuillin A, Reichert MC, Krawczyk M, Casper M, Lammert F, Braun F, von Schönfels W, Hinz S, Burmeister G, Hellerbrand C, Teufel A, Feldman A, Schattenberg JM, Bantel H, Pathil A, Demir M, Kluwe J, Boettler T, Ridinger M, Wodarz N, Soyka M, Rietschel M, Kiefer F, Weber T, Marhenke S, Vogel A, Hinrichsen H, Canbay A, Schlattjan M, Sosnowsky K, Sarrazin C, von Felden J, Geier A, Deltenre P, Sipos B, Schafmayer C, Nothnagel M, Aigner E, Datz C, Stickel F, Morgan MY, Hampe J, Berg T, Trautwein C. Heterozygous carriage of the alpha1-antitrypsin PiZ variant increases the risk to develop liver cirrhosis. Gut 2019;68:1099-107.
  • Lepida A, Marot A, Trépo E, Degré D, Moreno C, Deltenre P. Systematic review with meta-analysis: Automated low-flow ascites pump therapy for refractory ascites. Aliment Pharmacol Ther 2019;50:978-87.
  • Deltenre P, Trépo E, Fujiwara N, Goossens N, Marot A, Dubois M, Spahr L, Henrion J, Moreno C, Hoshida Y. The gene signature-MELD score and alcohol relapse determine long-term prognosis of patients with severe alcoholic hepatitis. Liv Int 2020;40:565-70.
  • Stickel F, Lutz P, Buch S, Nischalke HD, Silva I, Rausch V, Fischer J, Weiss KH, Gotthardt D, Rosendahl J, Marot A, Elamly M, Krawczyk M, Casper M, Lammert F, Buckley TWM, McQuillin A, Spengler U, Eyer F, Vogel A, Marhenke S, von Felden J, Wege H, Sharma R, Atkinson S, Franke A, Nehring S, Moser V, Schafmayer C, Spahr L, Lackner C, Stauber RE, Canbay A, Link A, Valenti L, Grove JI, Aithal GP, Marquardt JU, Fateen W, Zopf S, Dufour JF, Trebicka J, Datz C, Deltenre P*, Mueller S, Berg T, Hampe J, Morgan MY. Genetic variation in HSD17B13 reduces the risk of developing cirrhosis and hepatocellular carcinoma in alcohol misusers. Hepatology 2020;72:88-102. * Co dernier auteur
  • Degré D, Stauber RE, Verset L, Englebert G, Rainer F, Spindelboeck W, Djimi H, Trépo E, Gustot T, Lackner C, Deltenre P*, Moreno C*. Long-term outcome of symptomatic alcoholic hepatitis with a Maddrey discriminant function < 32. J Hepatol 2020;72:636-42. * Co dernier auteur
  • Marot A, Singal AK, Moreno C, Deltenre P. Systematic review with meta-analysis of randomized controlled trials: usefulness of granulocyte colony-stimulating factor in alcoholic hepatitis. J Hep Reports 2020 Jun 18;2:100139.
  • Innes H, Buch S, Hutchinson S, Neil Guha I, Morling JR, Barnes E, Irving W, Forrest E, Pedergnan V, Goldberg D, Aspinall E, Barclay S, Hayes P, Dillon J, Nischalke HD, Lutz P, Spengler U, Fischer J, Berg T, Eyer F, Datz C, Mueller S, Peccerella T, Deltenre P, Marot A, Soyka M, McQuillin A, Morgan MY, Hampe J, Stickel F. Genome-wide Association Study for Alcohol-related Cirrhosis Identifies Risk Loci in MARC1 and HNRNPUL1. Gastroenterology 2020;159:1276-89.
  • Dubois M, Sciarra A, Trépo E, Marot A, Saldarriaga J, Moreno C, Sempoux C, Deltenre P. Histologic parameter score does not predict short-term survival in severe alcoholic hepatitis. UEGJ 2020;8:1003-12.
  • Djebali-Trabelsi A, Marot A, Andre C, Deltenre P. Large-scale screening is not useful for identifying individuals with hepatitis B or C virus infection: a prospective Swiss study. J Viral Hepatitis 2021;12:1756-8.
  • Innes H, Nischalke HD, Guha N, Weiss KH, Irving W, Gotthardt D, Barnes E, Fischer J, Ansari A, Rosendahl J, Shang-Kuan L, Marot A, Pedergnana V, Casper M, Benselin J, Lammert F, McLauchlan J, Lutz P, Hamill V, Mueller S, Morling J, Eyer F, von Felden J, Link A, Vogel A, Marquardt J, Sulk S, Trebicka J, Valenti L, Datz C, Reiberger T, Schafmayer C, Berg Thomas, Deltenre P*, Hampe J*, Stickel F*, Buch S*. Variants APOE (rs429358) and TM6SF2 (rs187429064) confer risk to hepatocellular carcinoma. Hepatology Communications 2022;6:1213-26. * Co dernier auteur
  • Deltenre P, Labenz C, Schuchmann M. Quality of life as a therapeutic objective in the management of hepatic encephalopathy and the potential role of rifaximin-α. EJGH 2021;33 Suppl 1:e1032-e1038.
  • Artru F, Vietti-Violi N, Sempoux C, Vieira Barbosa J, Becce F, Sah N, Marot A, Deltenre P, Moschouri E, Fraga M, Hocquelet A, Duran R, Moradpour D, Rautou PE, Denys A. Long Term Results of Portal Vein Recanalisation without TIPSS insertion in the Context of Chronic Non-Cirrhotic Extrahepatic Portal Vein Obstruction with Severe Portal Hypertension. J Hep Reports 2022;4:100511.
  • Buch S , Innes H , Lutz P , Nischalke HD , Nattermann J , Marquardt JU , Fischer J , Weiss KH , Rosendahl J , Marot A , Krawczyk M, Casper M, Lammert F, Eyer F, Vogel A, Marhenke S, von Felden J, Sharma R, Atkinson S, McQuillin A, Schafmayer C, Strassburg C, Altmann H , Sulk S , Raghavan Thangapandi V , Brosch M , Lackner C, Stauber RE, Canbay A, Link A, Reiberger T, Mandorfer M, Semmler G, Scheiner B, Datz C, Romeo S, Ginanni Corradini S, Valenti L, Müller S, Morgan M, Dufour JF, Trebicka J, Berg T, Deltenre P*, Mueller S, Hampe J , Stickel F. Genetic variation in TERT modifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results from a genome-wide case-control study. Gut 2023;72:381-91. * Co dernier auteur
  • Caverenne L, Weichselbaum L, Van Hoof M, Deltenre P. An unusual cause of extrahepatic cholestasis associated with solid liver lesions: a case report. Acta gastroenterol Belgica 2023, 86(3), pp. 490–492.
  • Marot A, Henrion J, Knebel JF, Moreno C, Deltenre P. Individualized prediction of the risk of liver-related death in patients with alcoholic cirrhosis. Hepatology Communications 2023, 7(9), e0229.
  • Donati A, Henrion J, Regnier M, Deltenre P*, Marot A*. Abstinence is associated with better outcomes in patients with alcohol-related hepatocellular carcinoma: results of an observational study. Clinics and Research in Hepatology and Gastroenterology, 2023, 47(10), 102225. * Co dernier auteur
  • Weichselbaum L, Lepida A, Marot A, Trépo E, Moreno C, Deltenre P. Systematic review with meta-analysis: Salvage TIPS in patients with cirrhosis and refractory variceal bleeding. UEGJ 2022;10:874-87.
  • Cadranel JF, Ollivier-Hourmand I, Cadranel J, Thevenot T, Zougmore H, Nguyen-Khac E, Bureau C, Allaire M, Nousbaum JB, Loustaud-Ratti V, Causse X, Sogni P, Hanslik B, Bourliere M, Peron JM, Ganne-Carrié N, Dao T, Thabut D, Maitre B, Debzi N, Smadhi R, Sombie R, Kpossou R, Nouel O, Bissonnette J, Ruiz I, Medmoun M, Negrin-Dastis S, Deltenre P, Artru F, Raherison C, Elkrief L, Lemagoarou C. International survey among hepatologists and pneumologists on hepatic hydrothorax: plea for recommendations. BMC Gastroenterology, 2023, 23(1), 305.
  • Otero Sanchez L, Yongxiang C, Njimi H, Englebert G, Putignagno A, Lepida A, Degré D, Boon N, Gustot T, Deltenre P, Marot A, Devière J, Moreno C, Trépo E. A machine-learning-based classification of adult-onset diabetes identifies patients at risk for liver-related complications. J Hep Reports 2023, 5(8), 100791.
  • Deltenre P, Payencé A, Elkrief L, La Mura V, Artru F, Baiges A, China L, Colle I, Lemaitre E, Procopet B, Schiller D, Bureau C, Goria O, Ollivier I, Nuzzo A, Rautou PE, Plessier A, for VALDIG, an EASL consortium. Splanchnic vein thrombosis associated with SARS-CoV-2 infection: a VALDIG case-control study. J Hep Reports 2023, 5(11), 100894.

PUBLICATIONS EN TANT QUE CO-INVESTIGATEUR

LETTRES OU REVUES GENERALES DANS DES REVUES A COMITE DE LECTURE

  • Deltenre P, Willocx R, Van Vyve E. Lymphangiome kystique bénin chez un patient atteint de porphyrie aiguë intermittente. Gastroentérol Clin Biol 1997; 21: 229-32.
  • Schapira M, Maisin JM, Ghilain JM, De Maeght S, Deltenre P, Henrion J. Epidemiology of coeliac disease. Acta Gastroenterol Belg 2003; 66: 234-6.
  • Mathurin P, Dharancy S, Malapel M, Deltenre P, Texier F, Paris JC. Hépatite alcoolique : données physiopathologiques et perspectives thérapeutiques. Gastroenterol Clin Biol 2004; 28: 103-11.
  • Deltenre P, Bulois P, Henrion J, Paris JC, Mathurin P. La mesure du gradient de pression hépatique et de la pression variqueuse : quelle valeur informationnelle ? Quelle utilité en pratique courante ? HépatoGastro 2004; 4: 269-75.
  • Espeel B, Caulry C, Deltenre P, Mansvelt B, Vermonden J. Multilobular liver abscess due to Streptococcus bovis. J Chir 2004;141: 404-5.
  • Deltenre P, Mathurin P, Barraud H, Bronowicki JP, Jacquet E, Puche P, Jaber S, Navarro F, Pageaux GP. Principes de prise en charge des complications des malades cirrhotiques. Rev Prat 2005; 55: 1555-63.
  • Deltenre P, Valla DC. Ischemic cholangiopathy. J Hepatol 2006; 44: 806-17.
  • Deltenre P, Lebrec D, Mathurin P. Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites. Gastroenterology 2006; 130: 1372-3.
  • Louvet A, Boitard J, Dharancy S, Duriez A, Deltenre P, Paris JC, Mathurin P. La mésaventure thérapeutique du paracétamol chez le buveur excessif. Gastroentérol Clin Biol 2006; 30: 767-74.
  • Deltenre P, Valla DC. Cholangiopathie ischémique. HépatoGastro 2006; 13: 249-56.
  • Deltenre P, Valla DC. Ischemic cholangiopathy. Semin Liver Dis 2008; 28: 235-46.
  • Mathurin P, Deltenre P. Effect on binge drinking on the liver: an alarming public health issue? Gut 2009; 58: 613-17.
  • Deltenre P, Mathurin P. Consommation d’alcool et mortalité par cirrhose alcoolique Epidemiologie de la maladie alcoolique du foie et nouveaux enjeux. Gastroenterol Clin Biol 2009; 33: 1147-50.
  • Deltenre P. Virological tools for optimal management of chronic hepatitis C. Acta Gastroenterol Belg 2009; 72: 421-24.
  • Henrion, J, Deltenre P, de Maeght S, Brenard R. Augmentation massive des transaminases sériques chez un insuffisant respiratoire. HépatoGastro 2010; 17: 429-35.
  • Deltenre P, Mathurin P, Serfaty L. Reply to: « HCV infection, HOMA index and sustained virological response: the step we need to take before moving forward ». J Hepatol 2012;57:473.
  • Orlent H, Deltenre P, Francque S, Laleman W, Moreno C, Bourgeois S, Colle I, Delwaide J, De Maeght S , Mulkay JP, Stärkel P, Reynaert H. Update of the Belgian Association for the Study of the Liver Guidelines for the Treatment of Chronic Hepatitis C Genotype 1 with Protease Inhibitors. Acta Gastroenterol Belg 2012;75:245-59.
  • Moreno C, Deltenre P. Prise en charge de l’hépatite C en 2012 en Belgique. Rev Med Brux 2012; 33: 223-7.
  • Henrion J, Deltenre P. Decompensated cirrhosis … Are we gaining ground? Acta Clin Belg 2013;68:411-15.
  • Romeo S, Valenti L, Trépo E, Moreno C, Nahon P, Deltenre P. Response to the letter of Limagne et al. PNPLA3 (rs738409 C>G) variant and oxidative stress due to chronic liver damage. Hepatology 2014;60:1111-12.
  • de Vos M, Henrion J, Deltenre P. Response to the letter of Chitsaz et al. entitled: “The role of proton pump inhibitors in the occurrence of spontaneous bacterial peritonitis”. Liv Int 2014;34:964-65.
  • Hessler R, Godat S, Fraga M, Burgmann K, Doerig C, Deltenre P, Schoepfer A. Actualités en gastroentérologie et en hépatologie. Rev Med Suisse 2014;412-413:41-44.
  • Deltenre P, Moradpour D. Actualités diagnostiques et thérapeutiques dans le domaine de l’encéphalopathie hépatique. Rev Med Suisse 2014;440:1612-1616.
  • Deltenre P. Studies on the epidemiology of hepatitis B and C virus infections are still needed. J Hepatol 2015;62:25-27.
  • Abdelrahman K, Marot A, Deltenre P. Facteurs impliqués dans le développement et la progression de la maladie alcoolique du foie. Rev Med Suisse 2015;11:1604-7.
  • Deltenre P, Trépo E, Moreno C. Reply to the letter “The intensiveness of intensive nutrition therapy”. Gastroenterology 2016;151:377
  • Marot A, Trépo E, Doerig C, Moreno C, Deltenre P. SEMS should be considered in patients with cirrhosis and uncontrolled variceal bleeding. Hepatology 2016;64:2273.
  • Marot A, Vandenbulcke H, Knebel JF, Doerig C, Moreno C, Deltenre P. External validation of the nomogram for individualized prediction of HCC occurrence in patients with HCV-related compensated cirrhosis. Hepatology 2017;65:1419-21.
  • Duran R, Deltenre P, Denys A. Reply to the letter “Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma”. Gastroenterology 2017;152:1625-26.
  • Deltenre P, Marot A, Knebel JF, Doerig C, Henrion J, Moreno C. Effect of abstinence on the prognosis of patients with alcoholic liver disease: A word of caution. J Hepatol 2017;66 :1329-30.
  • Marcu C, Schiffer E, Aubert JD, Vionnet J, Yerly P, Deltenre P, Marot A. Le syndrome hépato-pulmonaire et l’hypertension porto-pulmonaire. Rev Med Suisse 2017;13:1464-69.
  • Deltenre P, Marot A, Dubois M, Trépo E, Moreno C. Assessment of the risk of alcohol relapse following liver transplantation for alcoholic hepatitis using a meta-analysis approach. J Hepatol 2018;68:1322-23.
  • Marot A, Knebel JF, Henrion J, Deltenre P. Individualized prediction of hepatocellular carcinoma occurrence in a large cohort of patients with cirrhosis. J Hepatol 2018;69:975-76.
  • Grillo M, Coulier B, Deltenre P. Oesophagoericadial fistula after atrial fibrillation catheter ablation. J Belg Soc Radiol 2019;103:3.
  • Deltenre P, Marot A, Moreno C. Outcomes after early liver transplantation for patients with severe alcoholic hepatitis: Additional evidence from a meta-analysis. Gastroenterology 2019:156:285-86.
  • Degré D, Stauber RE, Deltenre P, Lackner C, Moreno C. Reply to “Alcohol-related Liver Disease has a significant long-term mortality irrespective of the presence of steatohepatitis”. J Hepatol 2020;73:460.
  • Marot A, Moreno C, Deltenre P. Liver transplantation for alcoholic hepatitis: a current clinical overview. Expert Review of Gastroenterology & Hepatology 2020;14:591-600.
  • Deltenre P, Moreno C, Trépo E. Progressive cholangiopathy in Covid-19 patients: Other possible diagnoses than ketamine-induced cholangiopathy should be considered. J Hepatol 2021;75:989-90.
  • Mansour S, Lemmers A, Trépo E, Moreno C, Deltenre P. The clinical advantage of fixed 8-mm diameter VCX stents over passively expansible 8-to-10 mm VTS stents is not established in patients with cirrhosis and refractory ascites treated with TIPS. J Hep Reports 2021;6: eCollection 2021.
  • Deltenre P, Marot A. Prognostic value of histologic parameters in alcoholic hepatitis: a word of caution. J Hepatol 2021;75:1509-10.
  • Deltenre P, Zanetto A, Saltini D, Moreno C, Schepis F. The evolving role of intrahepatic portocaval shunting in patients with cirrhosis and ascites: Patient selection and technical choices. Hepatology 2023;77:640-58.
  • Deltenre P, Trépo E, Moreno C. The concept of MAFLD gathers patients with distinct disease progression trajectories. J Hepatol 2023;78:e-135-e136.
  • Lan T, Chen M, Tang C, Deltenre P. Recent developments in the management of ascites in cirrhosis. United European Gastroenterology Journal, 2024, 12(2), pp. 261–272.

 CHAPITRES DE LIVRES

  • Pol S, Cacoub P, Deltenre P, Durrbach A, Frydmann L, Izopet J, Kamar N, Longevialle R, Loustaud-Ratti V, Vallet-Pichard A. Rapport sur la prise en charge des personnes infectées par les virus de l’hépatite B et de l’hépatite C. Chapitre 20 : Problèmes spécifiques liés à l’insuffisance rénale, l’hémodialyse et la transplantation rénale. Editions EDK/Groupe EDP Sciences. Paris, 2014. Pages 443-57.
  • Degré D, Deltenre P, Moreno C. Alcoholic hepatitis: Moving towards personalized management. Therapy in liver diseases 2019. 2019 Licitelco Espana S.L. Pages 79-84.
  • Deltenre P. Hepatic artery occlusion and ischemic cholangiopathy. VALDIG book, Vascular disorders of the liver. Springer publisher 2022.
  • Moreno, C, Degré, D, Deltenre P. Alcoholic hepatitis. Comprehensive Guide to Hepatitis Advances. Elsevier publisher. Sous presse.

Mandats :

  • Membre de l’European Association for the Study of the Liver (EASL)
  • Membre de la Belgian Association for the Study of the Liver (BASL)
  • Membre de la Société Royale Belge de Gastro-entérologie (SRBG)
  • Membre de l’Association Française pour l’Etude du Foie (AFEF)
  • Membre du Club Francophone pour l’Etude de l’Hypertension Portale (CHTP)
  • Membre de la Swiss Association for the Study of the Liver (SASL)
  • Membre de la Société Suisse de Gastro-entérologie (SSG)
  • Membre du Swiss Experts in Viral Hepatitis (SEVHep), Switzerland (entre 2015 et 2018)
  • Membre du conseil d’administration du Club Francophone pour l’Etude de l’Hypertension Portale (CHTP) (entre 2004 et 2010)
  • Membre du steering committee de la Belgian Association for the Study of the Liver (BASL) (entre 2010 et 2013 et depuis 2021)
  • Membre de la Coalition belge contre le VHC (depuis 2020)
  • Trésorier de de la Belgian Association for the Study of the Liver (BASL) (entre 2021 et 2023)
  • Secrétaire de de la Belgian Association for the Study of the Liver (BASL) depuis 2023
  • Membre de VALDIG (Vascular Liver Disease Group)
  • Membre du steering committee de VALDIG (Vascular Liver Disease Group)
Téléchargez le CV du Dr Pierre DELTENRE en cliquant ici.